Opus Genetics (NASDAQ:IRD – Get Free Report)‘s stock had its “buy” rating reiterated by equities researchers at HC Wainwright in a research report issued to clients and investors on Friday,Benzinga r… [+2899 chars]...
Read moreWall Street Zen downgraded shares of Opus Genetics (NASDAQ:IRD – Free Report) from a hold rating to a sell rating in a research report sent to investors on Saturday. Other analysts also recently iss… [+2867 chars]...
Read moreDublin, June 26, 2025 (GLOBE NEWSWIRE) -- The "Retinitis Pigmentosa Market Opportunities and Strategies to 2034" report has been added to ResearchAndMarkets.com's offering. This report describes and… [+11183 chars]...
Read moreNew York, USA, June 16, 2025 (GLOBE NEWSWIRE) -- Comprehensive Age-related Macular Degeneration Market Analysis: Trends and Developments Across All Types According to DelveInsights analysis, the mar… [+9475 chars]...
Read more